According to Aurobindo Pharma 's latest financial reports the company's current earnings are $3.57 Billion USD. In 2023 the company made an earning of $0.49 Billion USD, an increase over its 2022 earnings that were of $0.32 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | $0.64 B | 29.66% |
2023 | $0.49 B | 55.34% |
2022 | $0.32 B | -38.78% |
2021 | $0.52 B | -47.85% |
2020 | $1.00 B | 92.99% |
2019 | $0.52 B | 17.55% |
2018 | $0.44 B | -13.37% |
2017 | $0.51 B | 5.61% |
2016 | $0.48 B | 19.84% |
2015 | $0.40 B | 4.56% |
2014 | $0.38 B | 112.18% |
2013 | $0.18 B | 91.27% |
2012 | $95.18 M |